49- Agool A, Glaudemans AWJM, Boersma HH, Dierckx RAJO, Vellenga E, Slart RHJA.
Radionuclide imaging of bone marrow disorders. Eur J Nucl Med Mol Imaging. 2011;38:
166–78. doi:10.1007/s00259-010-1531-0. - Eisenberg RL. Clinical imaging: an atlas of differential diagnosis. 5th ed. Philadelphia, PA:
Lippincott Williams & Wilkins. 2010;978-0-7817-8860-1, 0-7817-8860-9s. - Glaudemans AWJM, Signore A. FDG-PET/CT in infections: the imaging method of choice?
Eur J Nucl Med Mol Imaging. 2010;37:1986–91. doi:10.1007/s00259-010-1587-x. - Ady N, Zucker JM, Asselain B, Edeline V, Bonnin F, Michon J, Gongora R, Manil L. A new
123I-MIBG whole body scan scoring method – application to the prediction of the response of
metastases to induction chemotherapy in stage IV neuroblastoma. Eur J Cancer. 1995;31a:
256–61. - Suc A, Lumbroso J, Rubie H, Hattchouel JM, Boneu A, Rodary C, Robert A, Hartmann
O. Metastatic neuroblastoma in children older than one year: prognostic significance of the
initial metaiodobenzylguanidine scan and proposal for a scoring system. Cancer. 1996;77:
805–11. - Matthay KK, Edeline V, Lumbroso J, Tanguy ML, Asselain B, Zucker JM, Valteau-Couanet D,
Hartmann O, Michon J. Correlation of early metastatic response by 123I-metaiodobenzylguanidine
scintigraphy with overall response and event-free survival in stage IV neuroblastoma. J Clin
Oncol. 2003;21:2486–91. - Katzenstein HM, Cohn SL, Shore RM, Bardo DM, Haut PR, Olszewski M, Schmoldt J, Liu D,
Rademaker AW, Kletzel M. Scintigraphic response by 123I-metaiodobenzylguanidine scan
correlates with event-free survival in high-risk neuroblastoma. J Clin Oncol. 2004;22:
3909–15. - Bleeker G, van Eck-Smit BL, Zwinderman KH, Versteeg R, van Noesel MM, Kam BL,
Kaspers GJ, van Schie A, Kreissman SG, Yanik G, Hero B, Schmidt M, Laureys G, Lambert
B, Ora I, Schulte JH, Caron HN, Tytgat GA. MIBG scans in patients with stage 4 neuroblas-
toma reveal two metastatic patterns, one is associated with MYCN amplification and in
MYCN-amplified tumours correlates with a better prognosis. Eur J Nucl Med Mol Imaging.
2015;42:222–30. - Bleeker G, Tytgat GA, Adam JA, Caron HN, Kremer LC, Hooft L, van Dalen EC. 123I-MIBG
scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma. Cochrane Database
Syst Rev. 2015;9:Cd009263. - Matthay KK, Brisse H, Couanet D, Couturier J, Benard J, Mosseri V, Edeline V, Lumbroso J,
Valteau-Couanet D, Michon J. Central nervous system metastases in neuroblastoma: radio-
logic, clinical, and biologic features in 23 patients. Cancer. 2003;98:155–65. - Garaventa A, Gambini C, Villavecchia G, Di Cataldo A, Bertolazzi L, Pizzitola MR, De
Bernardi B, Haupt R. Second malignancies in children with neuroblastoma after combined
treatment with 131I-metaiodobenzylguanidine. Cancer. 2003;97:1332–8. - Weiss B, Vora A, Huberty J, Hawkins RA, Matthay KK. Secondary myelodysplastic syndrome
and leukemia following 131I-metaiodobenzylguanidine therapy for relapsed neuroblastoma.
J Pediatr Hematol Oncol. 2003;25:543–7.
3 Radiologic Procedures Used in Pediatric Stem Cell Transplantation